Latest Production News

Canadian Phosphate (ASX: CP8) secured $5.2 million through a rights issue and follow-on placement, positioning itself to accelerate exploration and development across key projects in Canada and the US.

LTR Pharma’s intranasal spray OROFLOW® has secured ethics approval for a clinical study targeting oesophageal motility disorders, marking its first foray beyond erectile dysfunction. The study, led by Dr Peter Wu, aims to validate a non-invasive alternative for swallowing difficulties in a market projected to reach US$8.1 billion by 2034.

Everest Metals Corporation (ASX: EMC) has completed a 3,078m grade control drilling program at its Mt Dimer Taipan Gold Project, delivering multiple high-grade gold intersections and advancing mining operations ahead of a resource update targeted for Q3 2026.

Galilee Energy has finished construction of the Zydeco-1 drilling site in Louisiana, setting the stage for drilling to commence in early July 2026. The well targets a substantial 13.7 billion cubic feet of gas and 610,000 barrels of condensate, underpinning the company’s US Gulf Coast growth ambitions.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

PointsBet’s FY26 nine-month report reflects a transitional period marked by MIXI’s 66.4% takeover, a slight revenue dip to AUD 186.6 million, and a near breakeven normalised EBITDA. Australian revenue softened by 4%, while Canada grew 13% driven by iGaming momentum.

Spenda Limited has pushed back the closing date for its retail entitlement offer by five days, aiming to complete a critical $8.545 million capital raise to support its turnaround plan and reduce debt.

Dundas Minerals has delivered high-grade gold assay results from 1m re-assays at its Rockland project near Kalgoorlie, validating a mineralised corridor extending over 2km from Capricorn through Rockland. The company is gearing up for extensive drilling to test depth extensions and linkages along this emerging gold system.

Daly Resources has debuted on the ASX after a $12 million IPO, positioning itself to explore fluorite, copper, and zinc in the Northern Territory, led by the Huckitta project.

Mount Ridley Mines has confirmed that high-grade scandium mineralisation at its Grass Patch Complex extends beyond the current Block 1 resource in all directions, based on re-assays of 481 historical drill samples. This expansion supports a resource upgrade and highlights the project's strategic importance amid tightening global scandium supply.